IGF2BP2 and neoplasm: Accordingly, xenograft assay showed that GAS5 overexpression attenuated tumor growth, while GAS5 silencing promoted tumor growth in vivo, which could be reversed by knockdown or overexpression of IGF2BP2 or QKI (Fig. 5M and N).